Marketing Aspects of Company-Sponsored Postmarketing Surveillance Studies
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 8 (1) , 1-8
- https://doi.org/10.2165/00002018-199308010-00001
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Review of company postmarketing surveillance studies.BMJ, 1992
- Channeling bias in the interpretation of drug effectsStatistics in Medicine, 1991
- Guidelines on postmarketing surveillance. Joint committee of ABPI, BMA, CSM, and RCGP.1988
- Postmarketing surveillance of adverse reactions to drugs.BMJ, 1984
- Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methodsJAMA, 1983
- W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.1980